Skip to contentBOCK LOUIS C — Orexigen Therapeutics, Inc. insider: 217 transactions · InsiderLensBOCK LOUIS C
- Director at SGX PHARMACEUTICALS, INC. · on record since Jan 31, 2006
- 10% owner at SGX PHARMACEUTICALS, INC. · on record since Jan 31, 2006
- Director at Somaxon Pharmaceuticals, Inc. · on record since Feb 1, 2006
- 10% owner at Somaxon Pharmaceuticals, Inc. · on record since Feb 1, 2006
- Director at Orexigen Therapeutics, Inc. · on record since Apr 25, 2007
- 10% owner at Orexigen Therapeutics, Inc. · on record since Apr 25, 2007
- 10% owner at ALIMERA SCIENCES INC · on record since Apr 28, 2010
- Director at VAXGEN INC · on record since Jul 30, 2010
- Director at ZOGENIX, INC. · on record since Nov 29, 2010
- 10% owner at ZOGENIX, INC. · on record since Nov 29, 2010
- Director at HORIZON PHARMA, INC. · on record since Jul 28, 2011
- Director at HEAT BIOLOGICS, INC. · on record since Sep 26, 2013
- Director at DYNAVAX TECHNOLOGIES CORP · on record since Feb 11, 2004
Insider trading activity of BOCK LOUIS C
- Transactions on record
- 217
- since Feb 23, 2004
- Open-market buys
- 9
- $18.1M
- Open-market sells
- 119
- $2.4M
- Companies traded
- 8
- last filing Mar 9, 2022
Figures computed from official regulatory filings — methodology.
Companies where BOCK LOUIS C has traded
- ZOGENIX, INC.40 tx · $11.4M · Mar 9, 2022
- Orexigen Therapeutics, Inc.136 tx · $3.7M · Jul 18, 2017
- HEAT BIOLOGICS, INC.2 tx · Jan 13, 2016
- HORIZON PHARMA, INC.13 tx · $6M · Aug 4, 2011
- VAXGEN INC1 tx · Jul 30, 2010
- SGX PHARMACEUTICALS, INC.17 tx · $10.7M · Aug 22, 2008
- Somaxon Pharmaceuticals, Inc.2 tx · $385K · Feb 1, 2006
- DYNAVAX TECHNOLOGIES CORP6 tx · Apr 18, 2005
Track record of BOCK LOUIS C
Statistical track record
Free- Open-market buys
- 9
- Last buy
- Nov 18, 2014
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of BOCK LOUIS C
Co-insiders of BOCK LOUIS C
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
BA Venture Partners VII, LLCHORIZON PHARMA, INC. +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 9, 2022 | OtherD | -9,000 | — | — | SEC |
| Mar 9, 2022 | OtherD | -22,000 | — | — | SEC |
| Mar 9, 2022 | OtherD | -20,000 | — | — | SEC |
| Mar 9, 2022 | OtherD | -20,000 | — | — | SEC |
| May 28, 2021 | AwardD | 22,000 | 0.00 USD | $0 | SEC |
| Jun 29, 2020 | AwardD | 13,000 | 0.00 USD | $0 | SEC |
| May 28, 2019 | AwardD | 13,000 | 0.00 USD | $0 | SEC |
| May 24, 2018 | AwardD | 15,000 | 0.00 USD | $0 | SEC |
| Mar 14, 2018 | ExerciseD | -5,625 | 0.00 USD | $0 | SEC |
| Mar 14, 2018 | ExerciseD | -6,250 | 0.00 USD | $0 | SEC |
| Mar 14, 2018 | ExerciseD | -6,250 | 0.00 USD | $0 | SEC |
| Mar 14, 2018 | Exercise | 218 | 20.00 USD | $4.4K | SEC |
| Mar 14, 2018 | Exercise | 218 | 28.00 USD | $6.1K | SEC |
| Mar 14, 2018 | Exercise | 5,625 | 12.00 USD | $67.5K | SEC |
| Mar 14, 2018 | Exercise | 1,562 | 30.96 USD | $48.4K | SEC |
| Mar 14, 2018 | ExerciseD | -218 | 0.00 USD | $0 | SEC |
| Mar 14, 2018 | Exercise | 218 | 32.00 USD | $7K | SEC |
| Mar 14, 2018 | ExerciseD | -218 | 0.00 USD | $0 | SEC |
| Mar 14, 2018 | ExerciseD | -4,375 | 0.00 USD | $0 | SEC |
| Mar 14, 2018 | Sell | -24,716 | 44.83 USD | $1.1M | SEC |
| Mar 14, 2018 | ExerciseD | -1,562 | 0.00 USD | $0 | SEC |
| Mar 14, 2018 | Exercise | 6,250 | 15.52 USD | $97K | SEC |
| Mar 14, 2018 | ExerciseD | -218 | 0.00 USD | $0 | SEC |
| Mar 14, 2018 | Exercise | 6,250 | 15.04 USD | $94K | SEC |
| Mar 14, 2018 | Exercise | 4,375 | 14.88 USD | $65.1K | SEC |